Mallinckrodt plc Stock News

Mallinckrodt (NYSEMKT: MNK ) stock isn't doing so hot on Wednesday after the pharmaceutical company gets ready for another bankruptcy filing. A press release from Mallinckrodt notes that it's going to

Mallinckrodt is planning to start bankruptcy proceedings in the coming days, the U.S. drugmaker said on Wednesday, as it struggles to make required settlement payments for lawsuits alleging that it he

Mallinckrodt PLC MNK, +5.09% said Wednesday it has entered a Restructuring Support Agreement with most of its first and second lien debtholders and the Opioid Master Disbursement Trust II on the terms

Agreement Supported by a Substantial Majority of Each of its First and Second Lien Debtholders and Opioid Trust Financial Restructuring Plan to Significantly Reduce Debt, Increase Free Cash Flow Gene

LOS ANGELES , Aug. 22, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit agai

2023 has unfolded as a pivotal year for investors and traders alike, specifically those keen on harnessing the potential of penny stocks. These stocks, often priced below $5, present unique opportunit

Drugmaker Mallinckrodt is talking to hedge funds about filing for bankruptcy and avoiding payments intended to help people addicted to opioids, the Wall Street Journal reported on Wednesday.

Shares of Mallinckrodt PLC MNK, +4.35% rose 5.5% in afternoon trading Friday, after the drugmaker disclosed that it will once again delay the $200 million opioid-settlement payment by a week, followin

Mallinckrodt PLC shares MNK, -5.26% surged 9% in the premarket trading after the drug maker and distributor said it was open to proposed transactions from debt holders as it keeps delaying a payment u

Mallinckrodt PLC MNK shares surged in the extended session Thursday after the Dublin-based drug maker and distributor said it was open to proposed transactions as it keeps delaying a payment under an

Drug maker Mallinckrodt MNK, on Monday said it paid roughly $17 million in interest that was due last Tuesday, as it tries to keep up with bill payments following a $1.7 billion opioid settlement foll

Mallinckrodt PLC MNK, -15.69% disclosed Friday that it has decided to further delay the $200 million opioid-settlement payment by a week. The payment was originally due on June 16, before payment was

Generic-drug maker Mallinckrodt MNK, +17.69% on Wednesday said it set aside more than $3.4 million in executive retention bonuses in the event of a possible filing for yet another bankruptcy. The move

Shares of Mallinckrodt PLC MNK, +24.14% shot up 26.5% in afternoon trading, after the drug maker said it reached an agreement to delay a $200 million opioid-settlement payment by a week. The stock's r

Mallinckrodt is seeking to postpone a $200 million opioid settlement payment, Bloomberg News reported on Thursday citing people with knowledge of the matter.